Eun-Jung Jang

Title: Eun-Jung Jang: Innovator in Oligonucleotide Research

Introduction

Eun-Jung Jang is a prominent inventor based in Pohang-si, South Korea. She has made significant contributions to the field of oligonucleotide research, particularly in the development of aptamers and methods for preparing oligonucleotide derivatives. With a total of 2 patents, her work has implications for diagnosing and treating diseases associated with nucleolin.

Latest Patents

Eun-Jung Jang's latest patents include the following:

1. **Nucleolin specific aptamer and use thereof** - This patent focuses on improved G-rich oligonucleotide (GRO) aptamers that are specific to nucleolin. It outlines a method for preparing these aptamers and their potential use in diagnosing and/or treating nucleolin-associated diseases.

2. **Method of preparing 5'-amino-linker oligonucleotides derivatives and analogous 5'-labeled-linker oligonucleotides therefrom** - This patent describes a method for preparing amino linker oligonucleotides. It details the steps involved in introducing an amino linker with a protecting group into the 5' terminus of an oligonucleotide and subsequently removing the protecting group to achieve a high yield of amino linker oligonucleotides.

Career Highlights

Eun-Jung Jang has worked with notable organizations such as the Postech Academy-Industry Foundation and Posco. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Eun-Jung has collaborated with esteemed colleagues, including Jung-Hwan Lee and Hyun-Gu Kang. These partnerships have fostered innovation and enhanced the impact of her research.

Conclusion

Eun-Jung Jang is a distinguished inventor whose work in oligonucleotide research has the potential to revolutionize diagnostics and treatment options for nucleolin-associated diseases. Her contributions continue to shape the future of this important field.